CLOs on the Move

Oncology Services International

www.thinkosi.com

 
Our mission is to form long term trusting relationships with healthcare providers to help them deliver outstanding patient outcomes and experiences. We will never compromise quality in creating value through cost-effective healthcare technology solutions. From the services we provide to the equipment and parts we deliver, we will help our customers meet the challenges of providing high quality care while containing cost.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.thinkosi.com
  • 400 Rella Boulevard Suite 123
    Montebello, NY USA 10901
  • Phone: 800.445.4516
  • Fax: http://www.thinkosi.com/about/company-leadership

Executives

Name Title Contact Details

Similar Companies

iData Research

iData Research Inc. is a Vancouver, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aerohive

Aerohive delivers cloud networking that transforms the Connected Experience. Our simple, secure, and scalable mobility solutions build on cloud networking, great Wi-Fi, and applications and insights, to create the Connected Experience Platform, enabling organizations to leverage the power of mobility to increase productivity, engage customers, and grow their business. At Aerohive, we believe that every access point is a starting point.

Bigfoot Biomedical

Bigfoot Biomedical is a new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes.

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.  

WHILL

WHILL was started by a group of automotive, consumer electronics, and medical device designers and engineers who dreamed of pushing the boundaries of pedestrian transportation for everyone, especially for those who have difficulty walking.